Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Arm Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Patients Using the Purified Free Fatty Acid, Eicosapentaenoic Acid

NCT00510692 is registered in ClinicalTrials.gov with S.L.A. Pharma AG as lead sponsor.

NCT NCT00510692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00510692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Arm Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Patients Using the Purified Free Fatty Acid, Eicosapentaenoic Acid
Lead sponsor
S.L.A. Pharma AG
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2006
Completion date
April 30, 2008
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial adenomatous polyposis coli, fap